STOP THE WAR! Let’s support Ukraine Together

Mountain Crest V (MCAG) to Combine with AUM Biosciences in $400M Deal

Mountain Crest V (MCAG) to Combine with AUM Biosciences in $400M Deal

Mountain Crest V (NASDAQ:MCAG) has entered into a definitive agreement to combine with biotech firm AUM Biosciences at an equity value of $400 million. Singapore-based AUM is working to develop a range of drugs that could improve the effectiveness of cancer treatments with its most advanced candidates entering Phase II. The combined company is expected
Read More

To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.